This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (146)
-
May 15, 2025 | Insight NeoGenomics opposes US PTAB discretionary denial, citing public health concerns
...Trial and Appeal Board “is thus important to ensure that the public has access to Petitioner’s new assay...
Sections: Intellectual Property
-
May 14, 2025 | Insight LG wins US PTAB challenge of Multimedia Technologies patent for smart TV tech
...Trial and Appeal Board finding all challenged claims unpatentable for obviousness....
Sections: Intellectual Property
-
May 12, 2025 | Insight US panel says CRISPR priority determination by Patent Board needs a second look
...The Patent Trial and Appeal Board applied the wrong standard for conception when finding The Broad Institute...
Sections: Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login